Abstract: A display device includes a housing, a display panel, a light source, a first acquirer, a second acquirer, and a stabilizer. The display panel is provided in the housing. The light source is provided in the housing, and includes an LED that irradiates the display panel with light. The first acquirer acquires a first temperature in a first region including a region where the light source is disposed in the housing. The second acquirer acquires a second temperature in a second region different from the first region. The stabilizer has a first adjustment mode for lighting the LED with maximum luminance as an adjustment mode for stabilizing luminance of the LED. The stabilizer operates the LED in the first adjustment mode in a case where a temperature difference between the first temperature and the second temperature is a first threshold value or more.

Abstract: The present invention relates to a stretchable nano-mesh bioelectrode having excellent air permeability and durability. Specifically, the stretchable nano-mesh bioelectrode includes a nanofiber elastic mesh sheet including polymer nanofibers formed by electrospinning; and a metal nanowire network having a portion impregnated onto the nanofiber elastic mesh sheet.

Abstract: The present invention relates to a device for measuring grip strength including a basis; a cover coupled to the basis to form an enclosed pressure space separated from the outside; a cap disposed between the basis and the cover and configured to form a sensing space separated from the pressure space; magnets mounted on the cap or the basis to form a magnetic field; and a magnetic sensor for detecting change in the magnetic field. With this configuration, when measuring the grip strength of the user's hand, accuracy or sensitivity may be increased.

Abstract: A display device includes a housing, a display panel, a light source, a first acquirer, a second acquirer, and a stabilizer. The display panel is provided in the housing. The light source is provided in the housing, and includes an LED that irradiates the display panel with light. The first acquirer acquires a first temperature in a first region including a region where the light source is disposed in the housing. The second acquirer acquires a second temperature in a second region different from the first region. The stabilizer has a first adjustment mode for lighting the LED with maximum luminance as an adjustment mode for stabilizing luminance of the LED. The stabilizer operates the LED in the first adjustment mode in a case where a temperature difference between the first temperature and the second temperature is a first threshold value or more.

Abstract: The present invention relates to a fusion protein in which transferrin is peptide-bonded to a terminal of a granulocyte-colony stimulating factor (G-CSF) protein or a G-CSF mutant protein in which the 116th threonine is substituted with cysteine in the amino acid sequence of the G-CSF. Specifically, the granulocyte-colony stimulating factor (G-CSF) mutant protein of the present invention or the transferrin fusion protein thereof displays a significantly increased specific activity and blood stability, compared with the conventional human G-CSF, and has a higher purification efficiency than the conventional PEGylated G-CSF characterized by the extended half-life, so that it can be advantageously used for preventing or treating ischemic diseases or neutropenia.

Abstract: The present invention relates to a patch type thermometer containing a polymer that can be phase changed from a solid phase to a liquid phase. The patch type thermometer provided in an aspect of the present invention demonstrates high precision since it does not include conductive particles which have been a reason of disadvantage of the conventional temperature sensor, and has the effect of no temperature deviation in repeated temperature measurements because it is composed of such a single polymer material that is phase changed in a specific temperature range so that the polymer material can be reversibly changed in the volume and shape.

Abstract: The present invention relates to a patch type thermometer containing a polymer that can be phase changed from a solid phase to a liquid phase. The patch type thermometer provided in an aspect of the present invention demonstrates high precision since it does not include conductive particles which have been a reason of disadvantage of the conventional temperature sensor, and has the effect of no temperature deviation in repeated temperature measurements because it is composed of such a single polymer material that is phase changed in a specific temperature range so that the polymer material can be reversibly changed in the volume and shape.

Abstract: The present invention relates to a fusion protein in which transferrin is peptide-bonded to a terminal of a granulocyte-colony stimulating factor (G-CSF) protein or a G-CSF mutant protein in which the 116th threonine is substituted with cysteine in the amino acid sequence of the G-CSF. Specifically, the granulocyte-colony stimulating factor (G-CSF) mutant protein of the present invention or the transferrin fusion protein thereof displays a significantly increased specific activity and blood stability, compared with the conventional human G-CSF, and has a higher purification efficiency than the conventional PEGylated G-CSF characterized by the extended half-life, so that it can be advantageously used for preventing or treating ischemic diseases or neutropenia.

Abstract: The present invention relates to a fusion protein in which transferrin is peptide-bonded to a terminal of a granulocyte-colony stimulating factor (G-CSF) protein or a G-CSF mutant protein in which the 116th threonine is substituted with cysteine in the amino acid sequence of the G-CSF. Specifically, the granulocyte-colony stimulating factor (G-CSF) mutant protein of the present invention or the transferrin fusion protein thereof displays a significantly increased specific activity and blood stability, compared with the conventional human G-CSF, and has a higher purification efficiency than the conventional PEGylated G-CSF characterized by the extended half-life, so that it can be advantageously used for preventing or treating ischemic diseases or neutropenia.

Abstract: The present invention relates to a fusion protein in which transferrin is peptide-bonded to a terminal of a granulocyte-colony stimulating factor (G-CSF) protein or a G-CSF mutant protein in which the 116th threonine is substituted with cysteine in the amino acid sequence of the G-CSF. Specifically, the granulocyte-colony stimulating factor (G-CSF) mutant protein of the present invention or the transferrin fusion protein thereof displays a significantly increased specific activity and blood stability, compared with the conventional human G-CSF, and has a higher purification efficiency than the conventional PEGylated G-CSF characterized by the extended half-life, so that it can be advantageously used for preventing or treating ischemic diseases or neutropenia.